Search

Your search keyword '"Zhang, Yu-Jing"' showing total 462 results

Search Constraints

Start Over You searched for: Author "Zhang, Yu-Jing" Remove constraint Author: "Zhang, Yu-Jing" Language english Remove constraint Language: english
462 results on '"Zhang, Yu-Jing"'

Search Results

6. Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

13. Designing (Hf,Ta)Fe2-based zero thermal expansion composites consisting of multiple Laves phases.

14. Dipicolinic acid reduces Epicoccum sorghinum symptoms on maize and inhibits tenuazonic acid biosynthesis.

15. Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma.

19. Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

20. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

22. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

29. Anomalous thermal expansion and enhanced magnetocaloric effect in <001>-textured MnxFe5–xSi3 alloys.

30. Proteomics Study of Benzene Metabolite Hydroquinone Induced Hematotoxicity in K562 Cells.

31. Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)

36. Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

39. Radiotherapy plays an important role in improving the survival outcome in patients with T1–2N1M0 breast cancer – a joint analysis of 4262 real world cases from two institutions

40. Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: Data from a phase III clinical trial.

Catalog

Books, media, physical & digital resources